ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 642328 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 642328; 2) Community: the network communities that were significantly associated with the response to NSC 642328; 3) Molecule: the relationships between components within communities and NSC 642328; 4) MDR: the compounds that were significantly associated with the NSC 642328.

NSC Compound Enrichment Correlation
NSC 736049 N-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-N'-(2-met hylimidazo[1,2-a]pyridin-3-yl)urea 0.00563900078161121 0.092837257
NSC 287459 Cytarabine AY 0.00617256681787881 0.54781691
NSC 681638 Camptothecin Derivative 0.00617256681787881 0.6844266
NSC 692736 Null 0.00617256681787881 0.60842036
NSC 693142 Null 0.00617256681787881 -0.019291011
NSC 693167 Null 0.00617256681787881 0.45055798
NSC 697192 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dihydroxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.00617256681787881 0.28174696
NSC 709237 Camptothecin Derivative 0.00617256681787881 0.64360515
NSC 723531 Resveratrol-3,5-diacetate 0.00617256681787881 0.25855809
NSC 750148 3-(2-Hydroxy-5-chloro-4-methylphenyl)-5-(2-phenylethene)-1-(4-sulfamylphenyl)-pyrazoline 0.00617256681787881 -0.06999579
Total:79  Current:14    [First] [Prev] [Next] [Last]